Illumina ILMN Stock
Illumina Price Chart
Illumina ILMN Financial and Trading Overview
| Illumina stock price | 106.93 USD |
| Previous Close | 204.84 USD |
| Open | 203.96 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 1000 |
| Day's Range | 203.17 - 211.24 USD |
| 52 Week Range | 173.45 - 248.87 USD |
| Volume | 1.78M USD |
| Avg. Volume | 1.24M USD |
| Market Cap | 33.19B USD |
| Beta (5Y Monthly) | 1.170422 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -8.15 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 238.25 USD |
ILMN Valuation Measures
| Enterprise Value | 33.93B USD |
| Trailing P/E | N/A |
| Forward P/E | 66.017296 |
| PEG Ratio (5 yr expected) | -6.43 |
| Price/Sales (ttm) | 7.461943 |
| Price/Book (mrq) | 4.9558554 |
| Enterprise Value/Revenue | 7.628 |
| Enterprise Value/EBITDA | 87.222 |
Trading Information
Illumina Stock Price History
| Beta (5Y Monthly) | 1.170422 |
| 52-Week Change | 12.09% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 248.87 USD |
| 52 Week Low | 173.45 USD |
| 50-Day Moving Average | 209.92 USD |
| 200-Day Moving Average | 209.96 USD |
ILMN Share Statistics
| Avg. Volume (3 month) | 1.24M USD |
| Avg. Daily Volume (10-Days) | 1.46M USD |
| Shares Outstanding | 158.1M |
| Float | 157.75M |
| Short Ratio | 3.63 |
| % Held by Insiders | 0.28% |
| % Held by Institutions | 93.54% |
| Shares Short | 4.99M |
| Short % of Float | 3.54% |
| Short % of Shares Outstanding | 3.16% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | January 1, 2023 |
| Most Recent Quarter (mrq) | April 2, 2023 |
| Next Fiscal Year End | January 1, 2024 |
Profitability
| Profit Margin | -100.87% |
| Operating Margin (ttm) | -0.47% |
| Gross Margin | 67.28% |
| EBITDA Margin | 8.74% |
Management Effectiveness
| Return on Assets (ttm) | -0.097% |
| Return on Equity (ttm) | -51.022% |
Income Statement
| Revenue (ttm) | 4.45B USD |
| Revenue Per Share (ttm) | 28.29 USD |
| Quarterly Revenue Growth (yoy) | -11.099% |
| Gross Profit (ttm) | 3.15B USD |
| EBITDA | 389M USD |
| Net Income Avi to Common (ttm) | -4487000064 USD |
| Diluted EPS (ttm) | -28.25 |
| Quarterly Earnings Growth (yoy) | -96.50% |
Balance Sheet
| Total Cash (mrq) | 1.52B USD |
| Total Cash Per Share (mrq) | 9.6 USD |
| Total Debt (mrq) | 3.06B USD |
| Total Debt/Equity (mrq) | 45.75 USD |
| Current Ratio (mrq) | 1.422 |
| Book Value Per Share (mrq) | 42.361 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 230M USD |
| Levered Free Cash Flow (ttm) | 448.88M USD |
Profile of Illumina
| Country | United States |
| State | CA |
| City | San Diego |
| Address | 5200 Illumina Way |
| ZIP | 92122 |
| Phone | 858 202 4500 |
| Website | https://www.illumina.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 11500 |
Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; and whole-genome sequencing kits, which sequence entire genomes of any size and complexity, and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. Further, it provides whole-genome sequencing, genotyping, NIPT, and product support services; and Galleri, a multi-cancer early detection test. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Further, it markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. Illumina, Inc. was incorporated in 1998 and is headquartered in San Diego, California.
Q&A For Illumina Stock
What is a current ILMN stock price?
Illumina ILMN stock price today per share is 106.93 USD.
How to purchase Illumina stock?
You can buy ILMN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Illumina?
The stock symbol or ticker of Illumina is ILMN.
Which industry does the Illumina company belong to?
The Illumina industry is Diagnostics & Research.
How many shares does Illumina have in circulation?
The max supply of Illumina shares is 159.3M.
What is Illumina Price to Earnings Ratio (PE Ratio)?
Illumina PE Ratio is now.
What was Illumina earnings per share over the trailing 12 months (TTM)?
Illumina EPS is -8.15 USD over the trailing 12 months.
Which sector does the Illumina company belong to?
The Illumina sector is Healthcare.
Illumina ILMN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16846.78 USD — |
+0.08
|
1.54B USD — | 16810.8 USD — | 16853.4 USD — | — - | 1.54B USD — |
| S&P 500 (Yahoo.com) GSPC | 5321.55 USD — |
<0.01
|
248.26M USD — | 5315.93 USD — | 5322.85 USD — | — - | 248.26M USD — |
| S&P 500 INDEX SPX | 5321.36 USD — |
<0.01
|
170.13M USD — | 5315.93 USD — | 5321.36 USD — | — - | 170.13M USD — |
| US100 NDX | 18742.59 USD — |
+0.15
|
128.49M USD — | 18710.9 USD — | 18750.3 USD — | — - | 128.49M USD — |
| Dow Jones U.S. Biotechnology In DJUSBT | 2878.01 USD — |
+0.12
|
6.34M USD — | 2860.55 USD — | 2882.7 USD — | — - | 6.34M USD — |
| NASDAQ 100 Equal Weighted Total NETR | 8863.69 USD — |
+0.22
|
— — | 8845.7 USD — | 8868.59 USD — | — - | — — |
| Nasdaq-100 ESG Net Notional Tot NDXESG24 | 1538.12 EUR 1681.37 USD |
+0.31
|
— — | 1534.84 EUR 1677.79 USD | 1539.27 EUR 1682.63 USD | — - | — — |
| Nasdaq-100 Micro Index XND | 187.45 USD — |
+0.16
|
— — | 187.11 USD — | 187.5 USD — | — - | — — |
| NASDAQ 100 Equal Weighted NDXE | 7500.07 USD — |
+0.22
|
— — | 7485.04 USD — | 7504.41 USD — | — - | — — |
| NASDAQ Composite Total Return I XCMP | 20498.15 USD — |
+0.1
|
— — | 20450.5 USD — | 20502.3 USD — | — - | — — |
| NASDAQ-100 PM Settlement Value XQC | 16331.98 USD — |
+1.13
|
— — | 16331.98 USD — | 16331.98 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ 100 Notional Net Total R XNDXNNR | 21600.66 USD — |
+0.17
|
— — | 21561.8 USD — | 21607.1 USD — | — - | — — |
| NASDAQ 100 Pre Market Indicator QMI | 18735.47 USD — |
+0.12
|
— — | 18720.2 USD — | 18740.5 USD — | — - | — — |
| NASDAQ 100 Ex Tech Total Return NXTR | 6167.77 USD — |
-0.09
|
— — | 6152.22 USD — | 6169.35 USD — | — - | — — |
- {{ link.label }} {{link}}